Supportive care and peer support for young women with breast cancer
Young, Empowered &Amp; Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Newly Diagnosed/Metastatic Intervention
This study is testing a web-based support program for young women with breast cancer to see if it helps them manage their symptoms and connect with others going through similar experiences.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | Female |
| Sponsor | Dana-Farber Cancer Institute Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT04379414 on ClinicalTrials.gov |
What this trial studies
This research focuses on providing supportive care and monitoring symptoms for young women aged 18-39 diagnosed with stage 0-IV breast cancer through a web-based portal called YES. Participants will be enrolled in a prospective interventional cohort study that includes randomization into one of four groups. The YES portal facilitates regular assessments, symptom tracking, and access to self-management resources, while also fostering a community through discussion boards. The study aims to enroll approximately 400 participants over a period of up to five years.
Who should consider this trial
Good fit: Ideal candidates are young women aged 18-39 who have been newly diagnosed with stage 0-III breast cancer or have an initial diagnosis of stage IV breast cancer.
Not a fit: Patients who are older than 39 or have already started treatment for breast cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life and symptom management for young women facing breast cancer.
How similar studies have performed: Other studies have shown success in using web-based platforms for symptom management and support in cancer care, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stage 0-3 * Female * diagnosed with breast cancer between the ages of 18-39 years * less than 3 months post diagnosis date of new primary or local recurrence (prior history of other cancer is allowed as long as treated with curative intent and no evidence of disease from that cancer) * has not started treatment for breast cancer diagnosis yet * is planning to get care at DFCI * be fluent in and able to read English * have internet access on a regular basis at the time of consent that can support the web-based platform * Stage IV * Female * initial diagnosis of breast cancer between the ages of 18-39 years * be fluent in and able to read English * have internet access on a regular basis at the time of consent that can support the web-based platform Exclusion Criteria: -
Where this trial is running
Boston, Massachusetts
- Dana Farber Cancer Institute — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Ann H Partridge, MD — Dana-Farber Cancer Institute
- Study coordinator: Ann H Partridge, MD
- Email: AHPARTRIDGE@PARTNERS.ORG
- Phone: 617-582-7942
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.